Who Should Be Targeted for CKD Screening? Impact of Diabetes, Hypertension, and Cardiovascular Disease

American Journal of Kidney Diseases

Volumn 53, Issue 3 SUPPL. 3, 2009, Pages

  Collins, Allan J ^a,b   Vassalotti, Joseph A ^c,d   Wang, Changchun ^a   Li, Suying ^a   Gilbertson, David T ^a   Liu, Jiannong ^a   Foley, Robert N ^a,b   Chen, Shu Cheng ^a   Arneson, Thomas J ^a  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NATIONAL KIDNEY FOUNDATION   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; chronic kidney disease; diabetes; health screening; hypertension

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 60249096239     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.07.057     Document Type: Article

References (22)

1. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
2. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
3. US Renal Data System. USRDS 2007 Annual Data Report (2007), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
4. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
5. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
6. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 (2001) 851-860
7. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
8. Bang H., Vupputuri S., Shoham D.A., et al. Screening for Occult Renal Disease (SCORED): A simple prediction model for chronic kidney disease. Arch Intern Med 167 (2007) 374-381
9. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Analytic and Reporting Guidelines. http://www.cdc.gov/nchs/nhanes.htm Accessed May 13, 2008
10. National Center for Health Statistics. National Health and Nutrition Examination Survey. NHANES tutorials. http://www.cdc.gov/nchs/nhanes.htm Accessed May 13, 2008
11. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
12. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Correction for Serum Creatinine for NHANES 1999-2000 Is Highly Recommended. http://www.cdc.gov/nchs/data/nhanes/frequency/lab18_doc.pdf Accessed May 13, 2008
13. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Follicle Stimulating Hormone, and Luteinizing Hormone. http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l40_b_doc.pdf Accessed May 13, 2008
14. National Center for Health Statistics: NHANES. Documentation, Codebook, and Frequencies. http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l40_c.pdf Accessed May 13, 2008
15. National Center for Health Statistics CfDCaP. The National Health and Nutrition Examination Survey (NHANES), Analytic and Reporting Guidelines. http://www.cdc.gov/nchs/hus.htm Accessed May 13, 2008
16. National Kidney Foundation. KEEP (Kidney Early Evaluation Program) Annual Data Report 2006. Am J Kidney Dis 49 (2007) S1-S160 (suppl 1)
17. Boulware L.E., Jaar B.G., Tarver-Carr M.E., et al. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 290 (2003) 3101-3114
18. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 30 (2007) S4-S41 (suppl 1)
19. De Ferranti S.D., and Osganian S.K. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diabetes Vasc Dis Res 4 (2007) 285-296
20. Del-Rio-Navarro B.E., Velazquez-Monroy O., Lara-Esqueda A., et al. Obesity and metabolic risks in children. Arch Med Res 39 (2008) 215-221
21. Abell J.E., Egan B.M., Wilson P.W., et al. Differences in cardiovascular disease mortality associated with body mass between black and white persons. Am J Public Health 98 (2008) 63-66
22. Johnson-Taylor W.L., Fisher R.A., Hubbard V.S., et al. The change in weight perception of weight status among the overweight: Comparison of NHANES III (1988-1994) and 1999-2004 NHANES. Int J Behav Nutr Phys Act 5 (2008) 9